FindTrial
Sign In

Verifying a parameter in saliva in three different conditions

Evaluation of salivary procalcitonin levels in post COVID19 condition associated with periodontitis and type2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/042306
Enrollment
80
Registered
2022-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

Ragulapadu chintaginjala Rupa tejaswini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Subjects with post covid 19 recovery =3 months 2)Subjects with probing depth more than 5mm in at least 2 teeth in each quadrant 3)Subjects who have not undergone any periodontal treatment in last 6 months 4)Age group includes 30-65 years 5)Glycated hemoglobin=6.5

Exclusion criteria

Exclusion criteria: 1)Pregnant women 2)Smokers 3)Cardiovascular diseases 4)Immunodeficiency disorders 5)Bleeding disorders 6)Oral cancerous lesions 7)Patients with fluctuated sugar levels 8)Other systemic disorders

Design outcomes

Primary

MeasureTime frame
1)Modified sulcular bleeding index(mSBI) 2)Plaque index (PI) 3)Clinical attachment level (CAL) 4)Probing pocket depth (PPD) 5)Immunochromatography test for procalcitonin. Timepoint: baseline—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactRagulapadu chintaginjala Rupa tejaswini

Narayana dental college and hospital Nellore

chava7@hotmail.com9441978737

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026